Individual #00361992

ID_report -
Reference -
Remarks -
Gender -
Consanguinity -
Country France
Population -
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases CPN1D
Owner name Christian Drouet
Database submission license Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 InternationalCreative Commons License
Created by Christian Drouet
Date created 2021-04-13 11:46:06 +02:00 (CEST)
Date last edited N/A


Phenotypes

carboxypeptidase N deficiency (CPN1D) (CPN1D)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000257385 Proband presenting with a CPN deficiency clinical phenotype, i.e. association of chronic urticaria and angioedema - - Familial - - - - - Christian Drouet



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000363220 DNA SEQ - - CPN1 3 Christian Drouet



Variants

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
10 Parent #2 +?/+? ACMG pathogenic (recessive) g.101824970G>A g.100065161G>A 986C>T - CPN1_000010 Thr245 is a conserved residue among species and with CPM. p.(Thr245Met) meets ACMG criteria PS3, PS4, PM1, PM3, PP3, PP4, PP5 Informations from MoBiDic (https://mobidetails.iurc.montp.inserm.fr/MD/vars/CPN1): Predicted as damaging (0.001 SIFT), probably damaging (1.00 Polyphen2), damaging (0.753 ClinPred) and tolerated (2.72 FATHMM) Proband also carrier of a rs3788853 (XPNPEP2 NM_003399.5:c.-2399C>A; NC_000023.10:g.128870791C>A) identified as a risk marker for HAE-FXII and ACEi angioedema Journal: Vincent 2024 - rs371070915 Germline yes 0.00002 - - - Christian Drouet CPN1 - - - - 4 NM_001308.2:c.734C>T - r.(?) p.(Thr245Met) - - - - - - - - - - - - - -
10 Parent #1 +/+ ACMG pathogenic (recessive) g.101829514C>T g.100069757C>T c.[533G>A];[734C>T] - CPN1_000003 Both variants are predicted to be deleterious (SIFT), damaging (ClinPred) and probably damaging (PolyPhen), polymorphic for p.(Gly178Asp) or disease-causing for p.(Thr245Met) according to MutationTaster (Table 3). The observations of both variations meet the ACMG criteria PS3, PS4, PM1, PM2, PP3, PP4, PP5, and BP6 specifically for p.(Gly178Asp), along with a pathogenic (recessive) characterization as evaluated by InterVar. Controversy: introduced in ClinVar as pathogenic by OMIM and as benign by Mendelics, Sao Paulo Brazil Journal: Vincent 2024 ClinVar-SCV000027198 rs61751507 Germline yes 3.4E-03 - - - Christian Drouet CPN1 - - - - 3 NM_001308.2:c.533G>A - r.(?) p.(Gly178Asp) - - - - - - - - - - - - - -
X Unknown ?/. - association g.128870791C>A g.129736814C>A c.-2399C>A - XPNPEP2_000027 risk marker for ACEi angioedema, FXII-HAE and C1-INH-HAE ClinGen IDCA121578 Journal: Duan 2005 Journal: Duan 2009 Journal: CiliaLaCorte 2011 ClinVar-SCV000032557.2 rs3788853 Germline - - - - - Christian Drouet XPNPEP2 - - - - _1 NM_003399.5:c.-2399C>A - r.(=) p.(=) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.